Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT03955146 · TERMINATED
Trial details
- NCT number
- NCT03955146
- Sponsor
- Kyntra Bio
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2023-03-20
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.